These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1162 related items for PubMed ID: 24463007

  • 1. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N, Möllmann K, Milde-Langosch K, Müller V, Schumacher U, Brandt B, Pantel K, Jücker M.
    Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
    [Abstract] [Full Text] [Related]

  • 2. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
    Lyu H, Huang J, Edgerton SM, Thor AD, He Z, Liu B.
    Int J Clin Exp Pathol; 2015 May; 8(6):6143-56. PubMed ID: 26261492
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways.
    Ghayad SE, Vendrell JA, Ben Larbi S, Dumontet C, Bieche I, Cohen PA.
    Int J Cancer; 2010 Jan 15; 126(2):545-62. PubMed ID: 19609946
    [Abstract] [Full Text] [Related]

  • 5. Estradiol rapidly activates Akt via the ErbB2 signaling pathway.
    Stoica GE, Franke TF, Wellstein A, Czubayko F, List HJ, Reiter R, Morgan E, Martin MB, Stoica A.
    Mol Endocrinol; 2003 May 15; 17(5):818-30. PubMed ID: 12554767
    [Abstract] [Full Text] [Related]

  • 6. Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity.
    Lindberg K, Helguero LA, Omoto Y, Gustafsson JÅ, Haldosén LA.
    Breast Cancer Res; 2011 Apr 14; 13(2):R43. PubMed ID: 21492444
    [Abstract] [Full Text] [Related]

  • 7. Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells.
    Grabinski N, Bartkowiak K, Grupp K, Brandt B, Pantel K, Jücker M.
    Cell Signal; 2011 Dec 14; 23(12):1952-60. PubMed ID: 21777670
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway.
    Guo S, Sonenshein GE.
    Mol Cell Biol; 2004 Oct 14; 24(19):8681-90. PubMed ID: 15367686
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Selective hormone-dependent repression of estrogen receptor beta by a p38-activated ErbB2/ErbB3 pathway.
    St-Laurent V, Sanchez M, Charbonneau C, Tremblay A.
    J Steroid Biochem Mol Biol; 2005 Feb 14; 94(1-3):23-37. PubMed ID: 15862947
    [Abstract] [Full Text] [Related]

  • 14. Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha.
    Weitsman GE, Weebadda W, Ung K, Murphy LC.
    Breast Cancer Res Treat; 2009 Nov 14; 118(2):269-79. PubMed ID: 18941890
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling.
    Liu B, Ordonez-Ercan D, Fan Z, Huang X, Edgerton SM, Yang X, Thor AD.
    Mol Cancer Res; 2009 Nov 14; 7(11):1882-92. PubMed ID: 19861407
    [Abstract] [Full Text] [Related]

  • 17. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.
    Blanchard Z, Paul BT, Craft B, ElShamy WM.
    Breast Cancer Res; 2015 Jan 13; 17(1):5. PubMed ID: 25583261
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling.
    Scherbakov AM, Sorokin DV, Tatarskiy VV, Prokhorov NS, Semina SE, Berstein LM, Krasil'nikov MA.
    IUBMB Life; 2016 Apr 13; 68(4):281-92. PubMed ID: 26892736
    [Abstract] [Full Text] [Related]

  • 20. ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2.
    Pancholi S, Lykkesfeldt AE, Hilmi C, Banerjee S, Leary A, Drury S, Johnston S, Dowsett M, Martin LA.
    Endocr Relat Cancer; 2008 Dec 13; 15(4):985-1002. PubMed ID: 18824559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.